During the past decade, Willis-Knighton Physician Network conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Willis-Knighton Physician Network" #1 sponsor was "Allergan" with 3 trials, followed by "Sucampo Pharma Americas, LLC" with 3 trials sponsored, "Forest Laboratories" with 2 trials sponsored, "Aravive, Inc." with 1 trials sponsored and "Purdue Pharma LP" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Willis-Knighton Physician Network" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "Sucampo AG" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Willis-Knighton Physician Network" are "Constipation - Functional" (3 trials), "Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials), "Chronic Pain" (1 trials) and "Down Syndrome" (1 trials). Many other conditions were trialed in "Willis-Knighton Physician Network" in a lesser frequency.

Most popular intervention types in "Willis-Knighton Physician Network" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Lubiprostone" (3 trials), "Relamorelin" (3 trials), "Batiraxcept" (1 trials) and "Buprenorphine transdermal system" (1 trials). Other intervention names were less common.

The vast majority of trials in "Willis-Knighton Physician Network" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Willis-Knighton Physician Network". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Willis-Knighton Physician Network, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Willis-Knighton Physician Network, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".